Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease
ConclusionPyridoxamine modulates oxidative stress, advanced glycation end products, TNF ‐α transcripts levels, and metabolic disturbances, being a potential treatment for nonalcoholic fatty liver disease‐associated microcirculatory and metabolic complications.
Source: Microcirculation - Category: Research Authors: Evelyn Nunes Goulart da Silva Pereira,
Raquel Rangel Silvares,
Edgar Eduardo Ilaquita Flores,
Karine Lino Rodrigues,
Anissa Daliry Tags: ORIGINAL ARTICLE Source Type: research
More News: Diets | Fatty Liver Disease (FLD) | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Perfusion | Research | Urology & Nephrology | Vitamin B6 | Vitamins